Vitreomacular Adhesion

Top drugs studied for this disease

EMA withdrawal · 2025-06-19
EMA Withdrawn: Jetrea (ocriplasmin) — Inceptua AB
The EMA has withdrawn Jetrea (ocriplasmin) from the European market; the marketing authorization holder is Inceptua AB, with the withdrawal …
CLINICAL_TRIALS withdrawal · 2016-02-02
Clinical Trial Update: Intravitreal Gas for Vitreomacular Adhesion [NA]
A clinical trial investigating intravitreal gas for vitreomacular adhesion has been withdrawn.